Are prophylactic antibiotics necessary prior to transarterial chemoembolization for hepatocellular carcinoma in patients with native biliary anatomy?
AUTHORS
Watchmaker
JM ,
Lipnik
AJ ,
Fritsche
MR ,
Baker
JC ,
Mouli
SK ,
Geevarghese
S ,
Banovac
F ,
Omary
RA ,
Brown
DB ,
. Journal of surgical oncology. 2018 3 7; ().
- PMID: 29513895 [PubMed].
ABSTRACT
Prophylactic antibiotics are frequently administered for transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC). In patients without previous biliary instrumentation, infection risk from TACE is low. We hypothesized that there is a negligible rate of infection in these patients without prophylactic antibiotics.
Prophylactic antibiotics are frequently administered for transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC). In patients without previous biliary instrumentation, infection risk from TACE is low. We hypothesized that there is a negligible rate of infection in these patients without prophylactic antibiotics.